PAXLOVID

paxlovid 1.jpg
paxlovid 2.jpg

Date

March 2022

Description

Paxlovid (ritonavir-boosted nirmatrelvir) are oral antiviral pills used for the treatment of mild to moderate COVID-19 disease. This box was prescribed under a US Food and Drug Administration (FDA) emergency use authorization (EUA) in March 2022.

Source

US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Pfizer BioNTech

Citation

“PAXLOVID,” The Global Health Chronicles, accessed June 17, 2024, https://globalhealthchronicles.org/items/show/8564.